Patents by Inventor Valerie JULIA

Valerie JULIA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENTS FOR PRURIGO NODULARIS
    Publication number: 20240141050
    Abstract: Described herein are treatments and preventions for prurigo nodularis (PN), antibodies and pharmaceutical compositions for use in the treatment or prevention of PN, and uses of an anti-IL-31RA antibody (e.g., nemolizumab) in the manufacture of a medicament for the treatment or prevention of PN. Also described herein are biomarkers of PN and methods of altering or improving these biomarkers via treatments with an antibody that binds to IL-31RA (e.g., nemolizumab).
    Type: Application
    Filed: August 25, 2023
    Publication date: May 2, 2024
    Inventors: Valerie JULIA, Jayendra Kumar KRISHNASWAMY, Christophe PIKETTY, Francois ROUSSEAU
  • METHODS OF TREATING SKIN DISORDERS
    Publication number: 20240058268
    Abstract: Disclosed herein are methods for treatment of a skin disorders using pharmaceutical compositions that reduces the expression of and/or inhibit the activity of various genes including chemokine (C-X-C motif) ligands such as CXCL13 and XCL1, and matrix-metalloproteinases such as MMP12 and MMP13. The pharmaceutical compositions effectively act on epidermal differentiation and proliferation as well as on innate and adaptive immune cells in pathogenesis of skin disorders such as acne.
    Type: Application
    Filed: August 24, 2023
    Publication date: February 22, 2024
    Applicant: GALDERMA HOLDING SA
    Inventors: Valerie JULIA, Jayendra Kumar KRISHNASWAMY
  • TREATMENTS FOR PRURIGO NODULARIS
    Publication number: 20220411518
    Abstract: Described herein are treatments and preventions for prurigo nodularis (PN), antibodies and pharmaceutical compositions for use in the treatment or prevention of PN, and uses of an anti-IL-31RA antibody (e.g., nemolizumab) in the manufacture of a medicament for the treatment or prevention of PN. Also described herein are biomarkers of PN and methods of altering or improving these biomarkers via treatments with an antibody that binds to IL-31RA (e.g., nemolizumab).
    Type: Application
    Filed: April 6, 2022
    Publication date: December 29, 2022
    Inventors: Valerie JULIA, Jayendra Kumar KRISHNASWAMY, Christophe PIKETTY, Francois ROUSSEAU
  • METHODS OF TREATING SKIN DISORDERS
    Publication number: 20220257509
    Abstract: Disclosed herein are methods for treatment of a skin disorders using pharmaceutical compositions that reduces the expression of and/or inhibit the activity of various genes including chemokine (C-X-C motif) ligands such as CXCL13 and XCL1, and matrix-metalloproteinases such as MMP12 and MMP13. The pharmaceutical compositions effectively act on epidermal differentiation and proliferation as well as on innate and adaptive immune cells in pathogenesis of skin disorders such as acne.
    Type: Application
    Filed: February 7, 2022
    Publication date: August 18, 2022
    Inventors: Valerie JULIA, Jayendra Kumar KRISHNASWAMY